USA - NYSE:EVH - US30050B1017 - Common Stock
The current stock price of EVH is 4.45 USD. In the past month the price decreased by -43.24%. In the past year, price decreased by -64.05%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 39.86 | 48.67B | ||
| DOCS | DOXIMITY INC-CLASS A | 31.07 | 9.54B | ||
| WAY | WAYSTAR HOLDING CORP | 27.54 | 7.04B | ||
| HTFL | HEARTFLOW INC | N/A | 2.98B | ||
| CERT | CERTARA INC | 16.56 | 1.33B | ||
| PHR | PHREESIA INC | N/A | 1.39B | ||
| SDGR | SCHRODINGER INC | N/A | 1.32B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.32B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.08B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 8.74 | 1.06B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 631.25 | 1.07B | ||
| CTEV | CLARITEV CORP | N/A | 965.47M |
Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. The company is headquartered in Arlington, Virginia and currently employs 4,500 full-time employees. The company went IPO on 2015-06-05. The firm offers three primary solutions: specialty care management services, total cost of care management and administrative services. The company provides comprehensive quality management for oncology and cardiology patients from diagnosis through advanced care planning services, as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes an integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.
EVOLENT HEALTH INC - A
1812 North Moore St, Suite 1705
Arlington VIRGINIA 22203 US
CEO: Seth Blackley
Employees: 4500
Phone: 15713896000
Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. The company is headquartered in Arlington, Virginia and currently employs 4,500 full-time employees. The company went IPO on 2015-06-05. The firm offers three primary solutions: specialty care management services, total cost of care management and administrative services. The company provides comprehensive quality management for oncology and cardiology patients from diagnosis through advanced care planning services, as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes an integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.
The current stock price of EVH is 4.45 USD. The price decreased by -11.71% in the last trading session.
EVH does not pay a dividend.
EVH has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
18 analysts have analysed EVH and the average price target is 15.98 USD. This implies a price increase of 259.1% is expected in the next year compared to the current price of 4.45.
EVOLENT HEALTH INC - A (EVH) has a market capitalization of 522.92M USD. This makes EVH a Small Cap stock.
You can find the ownership structure of EVOLENT HEALTH INC - A (EVH) on the Ownership tab.
ChartMill assigns a fundamental rating of 2 / 10 to EVH. EVH has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months EVH reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS decreased by -101.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.37% | ||
| ROE | -21.48% | ||
| Debt/Equity | 1.26 |
18 analysts have analysed EVH and the average price target is 15.98 USD. This implies a price increase of 259.1% is expected in the next year compared to the current price of 4.45.
For the next year, analysts expect an EPS growth of -62.35% and a revenue growth -26.38% for EVH